The role of signal transducer and activator of transcription-2 in the interferon response

Journal of Interferon and Cytokine Research

Volumn 32, Issue 3, 2012, Pages 103-110

  Steen, Håkan C ^a   Gamero, Ana M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; STAT2 PROTEIN;

HUMAN; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERFERONS; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; VIRUS DISEASES; VIRUSES;

EID: 84857818989     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0099     Document Type: Review

References (73)

1. Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A. 2009. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83(11):5408-5418.
2. Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, Williams KL, Harris E, Fernandez-Sesma A, Schindler C, García-Sastre A. 2010. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 8(5):410-421.
3. Banninger G, Reich NC. 2004. STAT2 nuclear trafficking. J Biol Chem 279(38):39199-39206.
4. Battcock SM, Collier TW, Zu D, Hirasawa K. 2006. Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. J Virol 80(9):4422-4430.
5. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383(6598):344-347.
6. Bluyssen HA, Levy DE. 1997. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J Biol Chem 272(7): 4600-4605.
7. Brierley MM, Fish EN. 2005. Functional relevance of the conserved DNA-binding domain of STAT2. J Biol Chem 280(13): 13029-13036.
8. Brierley MM, Marchington KL, Jurisica I, Fish EN. 2006. Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent. Febs J 273(7):1569-1581.
9. Chang HM, Paulson M, Holko M, Rice CM, Williams BR, Marie I, Levy DE. 2004. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc Natl Acad Sci U S A 101(26):9578-9583.
10. Chen L-S, Wei P-C, Liu T, Kao C-H, Pai L-M, Lee C-K. 2009. STAT2 hypomorphic mutant mice display impaired dendritic cell development and antiviral response. J Biomed Sci 16(1):22.
11. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr., Kuriyan J. 1998. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 93(5):827-839.
12. Cheon H, Stark GR. 2009. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci U S A 106(23):9373-9378.
13. Christian SL, Collier TW, Zu D, Licursi M, Hough CM, Hirasawa K. 2009. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels. J Virol 83(13):6717-6726.
14. Colamonici O, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski J. 1994. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol Cell Biol 14(12):8133-8142.
15. Donnelly RP, Kotenko SV. 2010. Interferon-lambda: A new addition to an old family. J Interferon Cytokine Res 30(8):555-564.
16. Du Z, Fan M, Kim JG, Eckerle D, Lothstein L, Wei L, Pfeffer LM. 2009. Interferon-resistant Daudi cell line with a Stat2 defect is resistant to apoptosis induced by chemotherapeutic agents. J Biol Chem 284(41):27808-27815.
17. Dumler I, Kopmann A, Wagner K, Mayboroda OA, Jerke U, Dietz R, Haller H, Gulba DC. 1999. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells. J Biol Chem 274(34): 24059-24065.
18. Farrar JD, Smith JD, Murphy TL, Leung S, Stark GR, Murphy KM. 2000. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat Immunol 1(1):65-69.
19. Fu XY. 1992. A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s). Cell 70(2):323-335.
20. Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE Jr. 1990. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A 87(21):8555-8559.
21. George CX, Das S, Samuel CE. 2008. Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. Virology 380(2):338-343.
22. Ghislain JJ, Fish EN. 1996. Application of genomic DNA affinity chromatography identifies multiple interferon-a-regulated Stat2 complexes. J Biol Chem 271(21):12408-12413.
23. Ghislain JJ, Wong T, Nguyen M, Fish EN. 2001. The interferoninducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J Interferon Cytokine Res 21(6): 379-388.
24. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. 2001. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci 98(12): 6680-6685.
25. Gupta S, Jiang M, Pernis AB. 1999. IFN-{alpha} Activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J Immunol 163(7):3834-3841.
26. Gupta S, Yan H, Wong LH, Ralph S, Krolewski J, Schindler C. 1996. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals. Embo J 15(5):1075-1084.
27. Hahm B, Trifilo MJ, Zuniga EI, Oldstone MB. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22(2):247-257.
28. Huang M, Qian F, Hu Y, Ang C, Li Z, Wen Z. 2002. Chromatinremodelling factor BRG1 selectively activates a subset of interferon-alpha-inducible genes. Nat Cell Biol 4(10):774-781.
29. Improta T, Schindler C, Horvath CM, Kerr IM, Stark GR, Darnell JE Jr. 1994. Transcription factor ISGF-3 formation requires phosphorylated Stat91 protein, but Stat113 protein is phosphorylated independently of Stat91 protein. Proc Natl Acad Sci U S A 91(11):4776-4780.
30. Jia D, Rahbar R, Fish EN. 2007. Interferon-inducible Stat2 activation of JUND and CLDN4: Mediators of IFN responses. J Interferon Cytokine Res 27(7):559-566.
31. Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M. 2005. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79(9):5414-5420.
32. Kadota S, Nagata K. 2011. pp32, an INHAT component, is a transcription machinery recruiter for maximal induction of IFN-stimulated genes. J Cell Sci 124(Pt 6):892-899.
33. Kessler DS, Veals SA, Fu X-Y, Levy DS. 1990. Interferon-a regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 4: 1753-1765.
34. Kim SH, Lee CE. 2011. Counter-regulation mechanism of IL-4 and IFN-alpha signal transduction through cytosolic retention of the pY-STAT6:pY-STAT2:p48 complex. Eur J Immunol 41(2):461-472.
35. Klampfer L, Huang J, Corner G, Mariadason J, Arango D, Sasazuki T, Shirasawa S, Augenlicht L. 2003. Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression. J Biol Chem 278(47):46278-46287.
36. Lau JF, Nusinzon I, Burakov D, Freedman LP, Horvath CM. 2003. Role of metazoan mediator proteins in interferon-responsive transcription. Mol Cell Biol 23(2):620-628.
37. Lau JF, Parisien JP, Horvath CM. 2000. Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors. Proc Natl Acad Sci U S A 97(13):7278-7283.
38. Li X, Leung S, Burns C, Stark GR. 1998. Cooperative binding of Stat1-2 heterodimers and ISGF3 to tandem DNA elements. Biochimie 80(8-9):703-710.
39. Li X, Leung S, Kerr IM, Stark GR. 1997. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol 17(4):2048-2056.
40. Lou YJ, Pan XR, Jia PM, Li D, Xiao S, Zhang ZL, Chen SJ, Chen Z, Tong JH. 2009. IFR-9/STAT2 functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res 69(8):3673-3680.
41. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JE Jr., Chen X. 2005. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 17(6):761-771.
42. Martinez-Moczygemba M, Gutch MJ, French DL, Reich NC. 1997. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alphastimulated transcription factor ISGF3. J Biol Chem 272(32): 20070-20076.
43. Matsumoto M, Tanaka N, Harada H, Kimura T, Yokochi T, Kitagawa M, Schindler C, Taniguchi T. 1999. Activation of the transcription factor ISGF3 by interferon-gamma. Biol Chem 380(6):699-703.
44. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. 2009. Dengue virus NS5 inhibits interferon-a signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 200(8):1261-1270.
45. Melen K, Kinnunen L, Julkunen I. 2001. Arginine/lysine-rich structural element is involved in interferon-induced nuclear import of STATs. J Biol Chem 276(19):16447-16455.
46. Morrow AN, Schmeisser H, Tsuno T, Zoon KC. 2011. A novel role for IFN-stimulated gene factor 3II in IFN-g signaling and induction of antiviral activity in human cells. J Immunol 186(3):1685-1693.
47. Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Lee PW, Ikeda Y. 2007. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: Implication for the defective interferon response in cancer cells. Mol Ther 15(8):1531-1536.
48. Nusinzon I, Horvath CM. 2003. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci U S A 100(25):14742-14747.
49. Park C, Lecomte MJ, Schindler C. 1999. Murine Stat2 is uncharacteristically divergent. Nucleic Acids Res 27:4191-4199.
50. Park C, Li S, Cha E, Schindler C. 2000. Immune response in Stat2 knockout mice. Immunity 13(6):795-804.
51. Paulson M, Press C, Smith E, Tanese N, Levy DE. 2002. IFNStimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol 4(2):140-147.
52. Perry ST, Buck MD, Lada SM, Schindler C, Shresta S. 2011. STAT2 Mediates Innate Immunity to Dengue Virus in the Absence of STAT1 via the Type I Interferon Receptor. PLoS Pathog 7(2):e1001297.
53. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375-386.
54. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE Jr. 1996. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol Cell Biol 16(1):288-293.
55. Ramachandran A, Parisien JP, Horvath CM. 2008. STAT2 is a primary target for measles virus V protein-mediated alpha/ beta interferon signaling inhibition. J Virol 82(17):8330-8338.
56. Rodriguez JJ, Parisien JP, Horvath CM. 2002. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76(22):11476-11483.
57. Rodriguez JJ, Wang L-F, Horvath CM. 2003. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 77(21):11842-11845.
58. Romero-Weaver AL, Wang HW, Steen HC, Scarzello AJ, Hall VL, Sheikh F, Donnelly RP, Gamero AM. 2010. Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2. Mol Cancer Res 8(1):80-92.
59. Sarkis PT, Ying S, Xu R, Yu XF. 2006. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J Immunol 177(7):4530-4540.
60. Scarzello AJ, Romero-Weaver AL, Maher SG, Veenstra TD, Zhou M, Qin A, Donnelly RP, Sheikh F, Gamero AM. 2007. A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis. Mol Biol Cell 18(7):2455-2462.
61. Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell JE Jr. 1994. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76(5):821-828.
62. Shuai K, Stark GR, Kerr IM, Darnell JE Jr. 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261(5129):1744-1746.
63. Stancato LF, David M, Carter-Su C, Larner AC, Pratt WB. 1996. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Chem 271(8):4134-4137.
64. Tang X, Gao J-S, Guan Y-j, McLane KE, Yuan Z-L, Ramratnam B, Chin YE. 2007. Acetylation-dependent signal transduction for type I interferon receptor. Cell 131(1):93-105.
65. Testoni B, Schinzari V, Guerrieri F, Gerbal-Chaloin S, Blandino G, Levrero M. 2011a. p53-paralog DNp73 oncogene is repressed by IFN[alpha]/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor. Oncogene 30(23):2670-2678.
66. Testoni B, Vollenkle C, Guerrieri F, Gerbal-Chaloin S, Blandino G, Levrero M. 2011b. Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2. J Biol Chem 286(23): 20217-20227.
67. Veals SA, Santa Maria T, Levy DE. 1993. Two domains of ISGF3 gamma that mediate protein-DNA and protein-protein interactions during transcription factor assembly contribute to DNA-binding specificity. Mol Cell Biol 13(1):196-206.
68. Wang J, Pham-Mitchell N, Schindler C, Campbell IL. 2003. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. J Clin Invest 112(4): 535-543.
69. Wen Z, Zhong Z, Darnell JE Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82(2):241-250.
70. Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JT, Schreiber RD, Schindler CW, Krolewski JJ. 1996. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J 15(5):1064-1074.
71. Yan R, Qureshi S, Zhong Z, Wen Z, Darnell JE Jr. 1995. The genomic structure of the STAT genes: Multiple exons in coincident sites in Stat1 and Stat2. Nucleic Acids Res 23(3):459-463.
72. Zhao W, Cha EN, Lee C, Park CY, Schindler C. 2007. Stat2-dependent regulation of MHC class II expression. J Immunol 179(1):463-471.
73. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski U, Hengel H. 2005. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 201(10):1543-1553.